Wnt5a has been described as a tumor promoter in melanoma, gastric, pancreas, prostate cancer, but as a tumor suppressor in HCC, neuroblastoma, leukemia, colon, and thyroid cancers [46]. This evidence concerns the gene WNT5A and thyroid gland carcinoma.